Fig. 4From: Prospective pharmacological methodology for establishing and evaluating anti-cancer drug resistant cell linesChanges in the SNU-228 and SNU-267 morphologies due to sunitinib exposure. The shapes of the cells were monitored in the control, sunitinib-resistant, and sunitinib removal cells. Scale bar, 100 μmBack to article page